Marie Skłodowska-Curie Actions Horizon 2020 RISE program has granted 1.3 million euros from the development of new methods of diagnosis and treatment of tuberculosis in a network project called Innovation in Tuberculosis – INNOVA4TB. We are happy to be a part of INNOVA4TB project, a collaborative initiative between 12 institutions from 6 countries (Spain, Sweden, […]
Foundation for Innovative New Diagnostics, FIND. As stated on FINDs website “Diagnosis is the first step on the path to treatment and the foundation of disease control and prevention”. FIND focuses on providing diagnostic solutions where they are needed, provides guidelines, policies as well as providing understanding of the diagnostic value in the community. EMPE […]
It was a great honor to represent Sweden and present our unique diagnostic solutions for the early-stage detection of bacterial infections and rapid genotyping of multidrug-resistant tuberculosis in the 2nd WHO conference held in New Delhi! A hearty thanks to all our Team Sweden, including Swedish Embassy, SweCare Foundation, Swedish Medtech, EMPE Diagnostics AB, ApiRays […]
InnoHEALTH 2018 is the third annual conference being organized in New Delhi, India. The mission is to gather the top healthcare experts around the world with all the possible stakeholders of health sector, and discuss and deliberate on interventions which could bring down the cost of healthcare delivery and improve the quality of care. This […]
EMPE is happy to announce that Catharina Lagerstam, who is well-known in the Swedish Finanical and Banking industry is taking charge as the new Chairman of the board. Welcome Catharina!
We are happy to announce that EMPE Diagnostics has secured a 10 MSEK investment.
We are overwhelmed for the recognition by SwedenBIO that launched the Precision Medicine – The Swedish Industry Guide 2018! SwedenBIO has launched a major new report representing the first effort to map the Swedish Precision Medicine Industry Landscape and showcase precision medicine companies in Sweden to the global life science community.
We are going with Sciety, an authorised Swedish financial private organisation. Invest in us for the future!
We are happy to announce the first phase of our clinical validation initiation at The Institute for Health Science Research Germans Trias i Pujol (IGTP).